CRLs Are the Low-Hanging Fruit of FDA Transparency, Experts Say

(MedPage Today) — FDA leaders claimed that publishing hundreds of complete response letters (CRLs) in a central database was embracing “radical transparency,” but critics think the move was more about optics, and argue the agency has bigger transparency…